Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.060
-0.050 (-2.37%)
At close: Aug 28, 2026, 4:00 PM EDT
2.100
+0.040 (1.94%)
After-hours: Aug 28, 2026, 7:32 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $5.75 million as of August 28, 2026. Its market cap has decreased by -46.22% in one year.
Market Cap
5.75M
Enterprise Value
5.56M
1-Year Change
-46.22%
Ranking
Category
Stock Price
$2.06
ChartMarket Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $5.75M, a decrease of -83.27%. That is a compound annual growth rate of -26.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 5.80M | -10.77% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.27M |
| Propanc Biopharma | 6.24M |
| Purple Biotech | 6.22M |
| Dermata Therapeutics | 6.15M |
| Enveric Biosciences | 6.11M |
| Kairos Pharma | 6.02M |
| PharmaCyte Biotech | 5.80M |
| Cardio Diagnostics Holdings | 5.62M |